| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $261K | +111.0% |
| R&D Expense | $13.6M | +13.2% |
| SG&A Expense | $6.7M | +8.3% |
| Operating Income | -$20.1M | -10.8% |
| Net Income | -$19.0M | -5.4% |
| EPS (Basic) | -$3.57 | -395.8% |
| EPS (Diluted) | -$3.57 | -395.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | +27.5% |
| Short-term Investments | $4.1M | -74.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $14.2M | -41.7% |
| Total Assets | $14.5M | -41.8% |
| Current Liabilities | $3.4M | -7.0% |
| Long-term Debt | $382K | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -4.2% |
| Capital Expenditures | $14K | -94.1% |
| Investing Cash Flow | $11.7M | +172.8% |
| Financing Cash Flow | $8.4M | +4204.6% |
| Free Cash Flow | -$18.1M | -2.9% |
| Total Liabilities |
| $3.5M |
| -9.5% |
| Stockholders' Equity | $11.0M | -47.8% |